Mexico Continues Reliance Strategy To Expand Drug Access
Executive Summary
Mexico aims to speed up the registration of generics and biosimilars.
You may also be interested in...
Mexico To Expand Recognition Of International GMP Certificates For Biologic Medicines
Moves to widen GMP certificate recognition are in line with World Health Organization recommendations on Good Reliance Practices and with the Mexican government’s strategy for regulatory certainty for the pharmaceutical sector, says the country’s drugs regulator.
UK Government Reveals New Statutory Pricing Scheme
The scheme still includes high rebate rates, but a controversial life cycle adjustment mechanism has been dropped.
Premature Filings Add To EU Regulatory Resource Challenge
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.